P44-4 A case report of four patients received ramucirumab monotherapy as second-line treatment for advanced gastric cancer

Autor:	Akiko Ichiyanagi, Shuji Sato, Haruo Shimizu, Motohiro Tani, Kei Onodera, Akari Ueno, Hiroyuki Kaneto
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Second line treatment business.industry Internal medicine medicine Hematology Advanced gastric cancer business Ramucirumab
Zdroj:	Annals of Oncology. 32:S353
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.05.761
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d4a4d94758bec41be56070cb7804e9da https://doi.org/10.1016/j.annonc.2021.05.761 Zobrazit plný text záznamu